附註:Includes bibliographical references.
FrontMatter -- Contents -- Workshop Summary -- INTRODUCTION AND BACKGROUND -- THE COLLABORATIVE MODELING EXERCISE -- MAJOR CHALLENGES TO MODELING THE COST-EFFECTIVENESS OF CRC SCREENING -- NEXT STEPS -- REFERENCES -- Appendixes -- Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults -- Appendix B Workshop Participants -- Appendix C Workshop Speaker and Staff Biographies -- Appendixes D-Q Introduction -- Appendix D Overview of Harvard Model -- Karen M. Kuntz, ScD.
Appendix E Description of the Laudabaum Colorectal Cancer Screening Model -- Uri Ladabaum, M.D., M.S. Appendix F MISCAN-colon: An Overview -- Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema -- Appendix G The Vanderbilt Colorectal Cancer Model -- R.M. Ness, R.W. Klein, R.S. Dittus -- Appendix H Overview of the Vijan Colorectal Cancer Screening Model -- Sandeep Vijan, M.D., M.S.
Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise -- Michael Pignone, M.D., Appendix J Recent Findings on Test Performance -- Brian P. Mulhall, M.D., M.P.H. -- Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening -- Martin L. Brown, Ph. D. -- Appendix L Current Evidence on Compliance -- Sally W. Vernon, M.A., Ph. D. -- Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries -- Todd Anderson, M.S.
Appendix N Preliminary Results from CDC's Estimate of the National Capacity for Colorectal Cancer Screening and Follow-Up -- Laura C. Seeff, M.D. Appendix O Colorectal Cancer Surveillance Testing After Polypectomy -- Deborah Schrag, M.D., M.P.H. -- Appendix P Natural History of Colorectal Adenomas and Cancer -- T.R. Levin, M.D. -- Appendix Q CISNET�Cancer Intervention and Surveillance -- Eric J. (Rocky) Feuer, Ph. D.
